Join
Live feed
·
INSIDERFilingvia Quantisnow
Nasus Pharma Ltd. logo

Chief Executive Officer Teleman Dan Benjamin bought $20,305 worth of Ordinary Shares (6,550 units at $3.10), increasing direct ownership by 4% to 163,541 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
NSRX· Nasus Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NSRX (Nasus Pharma Ltd.) and more on Quantisnow.